CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Birmingham, Alabama, United States and 197 other locations
This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-...
Phase 2, Phase 3
Birmingham, Alabama, United States and 47 other locations
Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...
Birmingham, Alabama, United States and 37 other locations
activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Birmingham, Alabama, United States
The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...
Phase 3
Birmingham, Alabama, United States and 199 other locations
To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advance...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
KRAS G12C-mutant non-small cell lung cancer (NSCLC), pancreatic duct adenocarcinoma (PDAC), biliary tract cancer (BTC), or colorectal cancer...
Phase 1, Phase 2
Birmingham, Alabama, United States and 31 other locations
The purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration re...
Phase 1
Birmingham, Alabama, United States and 24 other locations
This is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with s...
Phase 1
Birmingham, Alabama, United States and 16 other locations
This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of [225Ac]-FP...
Phase 1
Birmingham, Alabama, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal